| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 53 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Ryan Arthur F54 | Director | Sell | 100 | $692.81 | $69,281.16 | - | -14.9% | +18.3% | |
| Apr 1, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,000 | $701.82 | $701,820.00 | -4.8% | -14.9% | +18.3% | |
| Apr 1, 2022 | Larosa Joseph J66 | EVP General Counsel And Secret | Sell | 5,114 | $690.73 | $3,532,373.15 | -1.4% | -14.9% | +18.3% | |
| Apr 1, 2022 | Landry Robert E52 | EVP Finance CFO | Sale+OE | 316 | $695.81 | $219,875.20 | -0.5% | -14.9% | +18.3% | |
| Mar 31, 2022 | Schleifer Leonard S64 | President &CEO | Sell | 2,886 | $710.01 | $2,049,088.86 | -13.6% | -14.4% | +17.6% | |
| Mar 30, 2022 | Goldstein Joseph L | Director | Sale+OE | 2,431 | $700.00 | $1,701,700.00 | -28.6% | -14.1% | +17.2% | |
| Mar 30, 2022 | Bassler Bonnie L59 | Director | Sale+OE | 1,240 | $700.00 | $868,000.00 | -53.4% | -14.1% | +17.2% | |
| Mar 30, 2022 | Vagelos P Roy | Director | Sell | 28,572 | $700.01 | $20,000,685.72 | -16.0% | -14.1% | +17.2% | |
| Mar 30, 2022 | Brown Michael S49 | Director | Sale+OE | 1,930 | $699.00 | $1,349,070.00 | -47.1% | -14.1% | +17.2% | |
| Mar 29, 2022 | Landry Robert E52 | EVP Finance CFO | Sale+OE | 2,683 | $687.90 | $1,845,630.36 | -0.6% | -13.7% | +17.3% |